Chun Yang

Chun Yang

Auto-generated profile, based on publicly available information

Chun Yang

University of Electronic Science and Technology of China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in IEEE Signal Processing Letters
Verified
Journal Article
Closed access
CYChun Yang
Chun Yang
DSDian Sheng
Dian Sheng
BYBo Yang
Bo Yang
Wenfeng ZhengWenfeng Zheng
Wenfeng Zheng
Chao LiuChao Liu
Chao Liu
To reduce the radiation dose, sparse-view computed tomography (CT) reconstruction has been proposed, aiming to recover high-quality CT images from sparsely sampled sinogram. To eliminate the artifacts present in sparse-view CT images, a new dual-domain diffusion model (DDDM) is proposed, which is composed of a sinogram upgrading module (SUM) and an image refining module (IRM) connected in series. In the sinogram domain, a novel degrading and upgrading framework is defined, in which SUM is trained to upgrade sparse-view sinograms step by step to reverse the degradation process of CT images caused by successive down-sampling of scanning views. In the image domain, IRM adopts an improved denoising diffusion framework to further reduce remaining artifacts and restore image details, where a skip connection from the original sparse-view sinogram is introduced to constrain the generation of details. Our DDDM shows significant improvement over deep-learning baseline models in both classical similarity metrics and perceptual loss, and has good generalization to untrained organs.

30 July 2023 in TechRxiv
Verified
Preprint
Open access
PDF file
CYChun Yang
Chun Yang
DSDian Sheng
Dian Sheng
BYBo Yang
Bo Yang
WZWenfeng Zheng
Wenfeng Zheng
LYLirong Yin
Lirong Yin
CLChao Liu
Chao Liu
A new deep-learning approach, dual-domain diffu?sion model (DDDM), is proposed for sparse-view CT reconstruc?tion, which is composed of a sinogram upgrading module (SUM) and an image refining module (IRM) connected in series. In the sinogram domain, a novel degrading and upgrading framework is defined, in which SUM is trained to upgrade sparse-view sinograms step by step to reverse the degradation process of CT images caused by successive down-sampling of scanning views. In the image domain, IRM adopts an improved denoising diffusion framework to further reduce remaining artifacts and restore image details, where a skip connection from the original sparse?view sinogram is introduced to constrain the generation of details. Our DDDM shows significant improvement over deep-learning baseline models in both classical similarity metrics and perceptual loss, and has good generalization to untrained organs. We release our code at: https://github.com/YC-Markus/code-for-DDDM.

31 March 2023
Verified
Other
Open access
YHYi Hu
Yi Hu
CYChun Yang
Chun Yang
TATania Amorim
Tania Amorim
MMMOHSIN MAQBOOL
MOHSIN MAQBOOL
JLJenny Lin
Jenny Lin
JZJianjun Zhao
Jianjun Zhao
Normal morphology in other organs.

31 March 2023
Verified
Other
Open access
YHYi Hu
Yi Hu
CYChun Yang
Chun Yang
TATania Amorim
Tania Amorim
MMMOHSIN MAQBOOL
MOHSIN MAQBOOL
JLJenny Lin
Jenny Lin
JZJianjun Zhao
Jianjun Zhao
Table S1: MS/MS analyses of APE2 pull-down proteins in 293T cells

31 March 2023
Verified
Other
Open access
YHYi Hu
Yi Hu
CYChun Yang
Chun Yang
TATania Amorim
Tania Amorim
MMMOHSIN MAQBOOL
MOHSIN MAQBOOL
JLJenny Lin
Jenny Lin
JZJianjun Zhao
Jianjun Zhao
Cisplatin chemotherapy is standard care for many cancers but is toxic to the kidneys. How this toxicity occurs is uncertain. In this study, we identified apurinic/apyrimidinic endonuclease 2 (APE2) as a critical molecule upregulated in the proximal tubule cells (PTC) following cisplatin-induced nuclear DNA and mitochondrial DNA damage in cisplatin-treated C57B6J mice. The APE2 transgenic mouse phenotype recapitulated the pathophysiological features of C-AKI (acute kidney injury, AKI) in the absence of cisplatin treatment. APE2 pulldown-MS analysis revealed that APE2 binds myosin heavy-Chain 9 (MYH9) protein in mitochondria after cisplatin treatment. Human MYH9-related disorder is caused by mutations in MYH9 that eventually lead to nephritis, macrothrombocytopenia, and deafness, a constellation of symptoms similar to the toxicity profile of cisplatin. Moreover, cisplatin-induced C-AKI was attenuated in APE2-knockout mice. Taken together, these findings suggest that cisplatin promotes AKI development by upregulating APE2, which leads to subsequent MYH9 dysfunction in PTC mitochondria due to an unrelated role of APE2 in DNA damage repair. This postulated mechanism and the availability of an engineered transgenic mouse model based on the mechanism of C-AKI provides an opportunity to identify novel targets for prophylactic treatment of this serious disease.Significance:These results reveal and highlight an unexpected role of APE2 via its interaction with MYH9 and suggest that APE2 has the potential to prevent acute kidney injury in patients with cisplatin-treated cancer.

31 March 2023
Verified
Other
Open access
YHYi Hu
Yi Hu
CYChun Yang
Chun Yang
TATania Amorim
Tania Amorim
MMMOHSIN MAQBOOL
MOHSIN MAQBOOL
JLJenny Lin
Jenny Lin
JZJianjun Zhao
Jianjun Zhao
Slight increase of APE2 expression in mouse PTCs after carboplatin and oxaliplatin treatment.